Literature DB >> 9476080

A multinational study of the factorial structure and other characteristics of the Dartmouth COOP Functional Health Assessment Charts/WONCA.

R C Westbury, T B Rogers, T E Briggs, D J Allison, J Gérvas, H Shigemoto, W Elford.   

Abstract

BACKGROUND: The 'Dartmouth COOP Functional Health Assessment Charts/WONCA' constitute a relatively new derived instrument for assessing health status that is specifically intended for use in primary care on a world-wide basis. It needs further validation in its special area of use.
OBJECTIVES: Over a range of countries, social backgrounds and case mixes, our aim was (i) to examine the factorial structure of the instrument; (ii) to explore how well it was understood; (iii) to check its acceptability; and (iv) to assess the value of the pictures on the charts.
METHODS: The charts themselves, accompanied by a short questionnaire about the charts, were administered to 1719 patients at eight varied types of treatment centre in Canada, Japan, Nepal and Spain. The responses to the instrument were subjected to standard factor analysis and a special Q-type principal components analysis. The responses to direct questions about the charts were compared with the answers to open-ended questions.
RESULTS: Factor analysis suggested a shared factorial pattern for all sites, with the first two factors accounting for 88.5% of the variability in correlations between the charts across the sites. The individual questions were understood by most patients, but a substantial minority did not appear to grasp the underlying purpose of the instrument. The instrument was well accepted. The pictures were considered to be helpful by most respondents, especially those at the Nepal sites. The variability in the scores for the individual charts across sites was less than expected and not always in the expected direction.
CONCLUSIONS: The COOP/WONCA system continues to show promise, but needs more validation.

Entities:  

Mesh:

Year:  1997        PMID: 9476080     DOI: 10.1093/fampra/14.6.478

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  7 in total

1.  Lifestyle at 3 years of age and quality of life (QOL) in first-year junior high school students in Japan: results of the Toyama Birth Cohort Study.

Authors:  Hongbing Wang; Michikazu Sekine; Xiaoli Chen; Takashi Yamagami; Sadanobu Kagamimori
Journal:  Qual Life Res       Date:  2007-12-22       Impact factor: 4.147

2.  COOP/WONCA charts as a screen for mental disorders in primary care.

Authors:  Joao Mazzoncini de Azevedo-Marques; Antonio Waldo Zuardi
Journal:  Ann Fam Med       Date:  2011 Jul-Aug       Impact factor: 5.166

3.  What makes the dyspeptic patient feel ill? A cross sectional survey of functional health status, Helicobacter pylori infection, and psychological distress in dyspeptic patients in general practice.

Authors:  A O Quartero; M W Post; M E Numans; R A de Melker; N J de Wit
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

4.  Assessment of the COOP charts with and without pictures in a Swiss population.

Authors:  T V Perneger; E Chamot; J F Etter; J L Richard; S Gallant; P Ricciardi; A Iten; B Burnand
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

5.  Reliability and validity of the COOP/WONCA health status measure in patients with chronic obstructive pulmonary disease.

Authors:  K Stavem; H Jodalen
Journal:  Qual Life Res       Date:  2002-09       Impact factor: 4.147

6.  Application of the COOP/WONCA charts to aged patients with chronic obstructive pulmonary disease: a comparison between Japanese and Chinese populations.

Authors:  Midori Yamaguchi; Motoyuki Nakao; Hideto Obata; Hideki Ikeda; Tetsuro Kanda; Qiao Wang; Yoriko Hara; Hisamitsu Omori; Yoko Ishihara
Journal:  BMC Public Health       Date:  2013-08-15       Impact factor: 3.295

7.  [COOP/WONCA: Reliability and validity of the test administered by telephone].

Authors:  Eduardo J Pedrero-Pérez; José Manuel Díaz-Olalla
Journal:  Aten Primaria       Date:  2015-05-08       Impact factor: 1.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.